Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ramanathan

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Annals of Internal Medicine|August 1, 1987
Diltiazem and propranolol in mild to moderate essential hypertension as monotherapy or with hydrochlorothiazideB Massie, E P MacCarthy, K B Ramanathan, et al.
The American Journal of Cardiology|June 5, 1989
Influence of beta 2 agonism and beta 1 and beta 2 antagonism on adverse effects and plasma lipoproteins: results of a multicenter comparison of dilevalol and metoprololB J Materson, N D Vlachakis, S P Glasser, et al.
Archives of Internal Medicine|December 1, 1989
Dilevalol in severe hypertension. A multicenter trial of bolus intravenous dosingJ D Wallin, M E Cook, E Fletcher, et al.
International Journal of Cardiology|January 14, 2012
Association of gender with morbidity and mortality after isolated coronary artery bypass grafting. A propensity score matched analysisMahboob Alam, Vei-Vei Lee, McArthur A Elayda, et al.
Journal of the American College of Cardiology|January 15, 2002
Percutaneous coronary intervention versus coronary bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: The VA AWESOME multicenter registry: comparison with the randomized clinical trialDouglass A Morrison, Gulshan Sethi, Jerome Sacks, et al.
Controlled Clinical Trials|December 10, 1999
A multicenter, randomized trial of percutaneous coronary intervention versus bypass surgery in high-risk unstable angina patients. The AWESOME (Veterans Affairs Cooperative Study #385, angina with extremely serious operative mortality evaluation) investigators from the Cooperative Studies Program of the Department of Veterans AffairsD A Morrison, G Sethi, J Sacks, et al.
Journal of the American College of Cardiology|November 13, 2002
Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: outcome of diabetic patients in the AWESOME randomized trial and registrySteven P Sedlis, Douglass A Morrison, Jeffrey D Lorin, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Annals of Internal Medicine|August 1, 1987
Diltiazem and propranolol in mild to moderate essential hypertension as monotherapy or with hydrochlorothiazideB Massie, E P MacCarthy, K B Ramanathan, et al.
The American Journal of Cardiology|June 5, 1989
Influence of beta 2 agonism and beta 1 and beta 2 antagonism on adverse effects and plasma lipoproteins: results of a multicenter comparison of dilevalol and metoprololB J Materson, N D Vlachakis, S P Glasser, et al.
Archives of Internal Medicine|December 1, 1989
Dilevalol in severe hypertension. A multicenter trial of bolus intravenous dosingJ D Wallin, M E Cook, E Fletcher, et al.
International Journal of Cardiology|January 14, 2012
Association of gender with morbidity and mortality after isolated coronary artery bypass grafting. A propensity score matched analysisMahboob Alam, Vei-Vei Lee, McArthur A Elayda, et al.
Journal of the American College of Cardiology|January 15, 2002
Percutaneous coronary intervention versus coronary bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: The VA AWESOME multicenter registry: comparison with the randomized clinical trialDouglass A Morrison, Gulshan Sethi, Jerome Sacks, et al.
Controlled Clinical Trials|December 10, 1999
A multicenter, randomized trial of percutaneous coronary intervention versus bypass surgery in high-risk unstable angina patients. The AWESOME (Veterans Affairs Cooperative Study #385, angina with extremely serious operative mortality evaluation) investigators from the Cooperative Studies Program of the Department of Veterans AffairsD A Morrison, G Sethi, J Sacks, et al.
Journal of the American College of Cardiology|November 13, 2002
Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: outcome of diabetic patients in the AWESOME randomized trial and registrySteven P Sedlis, Douglass A Morrison, Jeffrey D Lorin, et al.
Pageof 9